Atria Wealth Solutions, Inc. Bio Line Rx Ltd. Transaction History
Atria Wealth Solutions, Inc.
- $8.74 Billion
- Q4 2024
A detailed history of Atria Wealth Solutions, Inc. transactions in Bio Line Rx Ltd. stock. As of the latest transaction made, Atria Wealth Solutions, Inc. holds 94,133 shares of BLRX stock, worth $315,345. This represents 0.0% of its overall portfolio holdings.
Number of Shares
94,133
Previous 94,133
-0.0%
Holding current value
$315,345
Previous $50,000
60.0%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding BLRX
# of Institutions
36Shares Held
2.83MCall Options Held
75.1KPut Options Held
5.1K-
Highbridge Capital Management LLC New York, NY1.01MShares$3.38 Million0.05% of portfolio
-
Cvi Holdings, LLC Wilmington, DE816KShares$2.73 Million4.05% of portfolio
-
Values First Advisors, Inc.166KShares$557,6040.02% of portfolio
-
Lpl Financial LLC Fort Mill, SC92KShares$308,2000.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA87.2KShares$292,1700.0% of portfolio
About BioLineRx Ltd.
- Ticker BLRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 61,524,500
- Market Cap $206M
- Description
- BioLineRx Ltd., a clinical-stage biopharmaceutical development company, focuses on oncology. The company develops Motixafortide, a peptide, which has completed Phase 3 clinical trials for the treatment of autologous stem cell mobilization and Phase 2a clinical trials for the treatment of pancreatic cancer; and that is in Phase 2 clinical trials ...